Adjuvant methods in macular hole surgery: Intraoperative plasma-thrombin mixture and postoperative fluid-gas exchange

Ophthalmic Surgery and Lasers

Volumn 32, Issue 3, 2001, Pages 198-207

  Blumenkranz, M S ^a   Ohana, E ^a   Shaikh, S ^a   Chang, S ^a   Coll, G ^a   Morse, L S ^a   De Bustros, S ^a  

^a STANFORD UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THROMBIN;

ADULT; AGED; ARTICLE; ENDOPHTHALMITIS; GAS EXCHANGE; HUMAN; INTRAOPERATIVE PERIOD; MAJOR CLINICAL STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA HOLE; RETINA MACULOPATHY; RETINA SURGERY; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY;

ADULT; AGED; AGED, 80 AND OVER; BLOOD; CHEMOTHERAPY, ADJUVANT; FEMALE; FIBRIN TISSUE ADHESIVE; FLUOROCARBONS; HUMANS; INTRAOPERATIVE CARE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PRONE POSITION; RETINAL PERFORATIONS; SAFETY; THROMBIN; TREATMENT OUTCOME; VISUAL ACUITY; VITRECTOMY; WOUND HEALING;

EID: 0035012154     PISSN: 10823069     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Reappraisal of biomicroscopic classification of stages of development of a macular hole
2. Macular holes
3. Idiopathic macular holes
4. Vitrectomy for prevention of macular holes. Results of a randomized multicenter clinical trial
5. Vitreous surgery for idiopathic macular holes. Results of a pilot study
6. Stage III macular hole surgery
7. Pars plana vitrectomy for treatment of stage II macular holes
8. Clinicopathologic study of bilateral macular holes treated with pars plana vitrectomy and gas tamponade
9. Vitreous surgery for macula holes
10. Vitreous surgery for macular holes
11. Late reopening of macular holes after initially successful treatment with vitreous surgery
12. Transforming growth factor-beta 2 for the treatment of full-thickness macular holes. A prospective randomized study
13. The effect of pars plana vitrectomy and transforming growth factor-beta 2 without epiretinal membrane peeling on full-thickness macular holes
14. Vitrectomy for the treatment of full-thickness stage 3 or 4 macular holes. Results of a multicentered randomized clinical trial
15. Transforming growth factor-beta 2 significantly enhances the ability to flatten the rim of subretinal fluid surrounding macular holes. Preliminary anatomic results of a multicenter prospective randomized study
16. Comparison of recombinant transforming growth factor-beta-2 and placebo as an adjunctive agent for macular hole surgery
17. Effects of intraocular bubble duration in the treatment of macular holes by vitrectomy and transforming growth factor-beta 2
18. Human autologous serum for the treatment of full-thickness macular holes. A preliminary study
19. A multi-centered clinical study of serum as adjuvant therapy for surgical treatment of macular holes
20. Serum contains chemoattractants for retinal pigment epithelial cells
21. Thrombin in the management of full thickness macular holes
22. Autologous fibrin glue - Preparation and clinical use
23. Effect of autologous platelet concentrate in surgery for idiopathic macular hole: Results of a multicenter, double-masked, randomized trial
24. Pharmacologic treatment of proliferative vitreoretinopathy interrelationship with the coagulation cascade
25. Effect of fibrin glues on the mechanical properties of healing wounds
26. +] on human skin fribroblast growth and collagen production
27. Effect of fibrin on morphologic characteristics of retinal pigment epithelial cells
28. Biologic tissue adhesive for vitreoretinal surgery
29. Closure of blepharoplasty incisions with autologous fibrin glue
30. Thrombin, infusion for the control of intraocular bleeding during vitreous surgery
31. The use of intravitreal thrombin to control hemorrhage during vitrectomy
32. RPE mediated collagen gel contraction inhibition by colchicine and stimulation by TGF-beta
33. Antibodies formed against fibrin glue components and their circulatory relevance
34. Development of antibodies to bovine and human factor V in two children after exposure to topical bovine thrombin
35. Retinal pigment epitheliopathy after macular hole surgery
36. An overview of potential applications of heparin in vitreoretinal surgery
37. Thrombin adhesive properties: Induction by plasmin and heparan sulfate
38. Treatment of reopened macular hole after vitrectomy by laser and outpatient fluid-gas exchange